By G HossainPosted on October 6, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Despite the regulatory delay, Novo is still expecting a 2027 launch for its hemophilia A drug denecimig. FDA extends review of Novo’s hemophilia A drug, citing manufacturing issues Post navigation BioSpace 40 Under 40 winners make their mark on biopharmaShionogi makes $2B rare disease play with IntraBio buy
